2011
SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate.
De Souza A, Solomon G, Strober B. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate. Bulletin Of The NYU Hospital For Joint Disease 2011, 69: 185-7. PMID: 22035400.Peer-Reviewed Original ResearchConceptsHidradenitis suppurativaInflammatory musculoskeletal disordersPrevious ineffective treatmentRefractory SAPHO syndromeSafety of infliximabOral antibioticsComplete remissionSAPHO syndromeFirst doseCutaneous featuresContinued treatmentUnknown etiologyCase reportAcne vulgarisMusculoskeletal disordersIneffective treatmentInfliximabSkin abnormalitiesSyndromeYoung adultsSuppurativaJoint stiffnessTreatmentRemissionArthritis
2006
Comparison of Tazarotene and Minocycline Maintenance Therapies in Acne Vulgaris: A Multicenter, Double-blind, Randomized, Parallel-Group Study
Leyden J, Thiboutot D, Shalita A, Webster G, Washenik K, Strober B, Shupack J. Comparison of Tazarotene and Minocycline Maintenance Therapies in Acne Vulgaris: A Multicenter, Double-blind, Randomized, Parallel-Group Study. JAMA Dermatology 2006, 142: 605-612. PMID: 16702498, DOI: 10.1001/archderm.142.5.605.Peer-Reviewed Original ResearchConceptsGreater global improvementMaintenance therapyTazarotene gelGlobal improvementLesion countsAcne vulgarisOpen-label treatment phaseParallel-group studyInflammatory lesion countSevere acne vulgarisOverall disease severityPlacebo capsulesMaintenance regimensReferral centerWeek 24Severe acneVehicle gelAmbulatory patientsWeek 12Minocycline therapyAntibiotic exposureMean reductionTreatment phasePatientsGreater efficacy